Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Cassava Sciences, Inc. (SAVA)

Pharmaceutical Preparations

https://www.cassavasciences.com

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300
AUSTIN, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/14/2000

Market Cap

1,367,321,700

Shares Outstanding

42,240,000

Weighted SO

42,236,919

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

ANVS --.--%

AXSM --.--%

RVPH --.--%

MCRB --.--%

AVXL --.--%

INMB --.--%

BIVI --.--%

CGTX --.--%

CVAC --.--%

Beta

-0.5670

Last Div

0.0000

Range

8.79-42.2

Chg

0.1100

Avg Vol

3146704

Mkt Cap

1367321700

Exch

NASDAQ

Country

US

Phone

512 501 2444

DCF Diff

25.5011

DCF

2.8889

Div Yield

0.0000

P/S

582.3346

EV Multiple

-8.4775

P/FV

6.9679

Div Yield %

0.0000

P/E

-85.6594

PEG

2.9651

Payout

0.0000

Current Ratio

4.0686

Quick Ratio

4.0686

Cash Ratio

3.7970

DSO

223.6635

DIO

0.0000

Op Cycle

223.6635

DPO

14114.4077

CCC

-13890.7441

Gross Margin

0.4212

Op Margin

-58.6899

Pretax Margin

-6.5468

Net Margin

-6.5468

Eff Tax Rate

-0.3571

ROA

-0.0631

ROE

-0.1098

ROCE

-0.7292

NI/EBT

1.0000

EBT/EBIT

0.1115

EBIT/Rev

-58.6899

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-52.3571

CF/Debt

0.0000

Equity Multi

1.2889

Rec Turnover

1.6319

Pay Turnover

0.0259

Inv Turnover

0.0000

FA Turnover

0.1099

Asset Turnover

0.0096

OCF/Share

-1.8660

FCF/Share

-1.8680

Cash/Share

4.4866

OCF/Sales

-36.7181

FCF/OCF

1.0011

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-937.1087

Div&CapEx Cov

-937.1087

P/BV

6.9679

P/B

6.9679

P/S

582.3346

P/E

-85.6594

P/FCF

-15.8427

P/OCF

-15.2731

P/CF

-15.2731

PEG

2.9651

P/S

582.3346

EV Multiple

-8.4775

P/FV

6.9679

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 08, 16:19 SAVA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Cassava Sciences, Inc. (SAVA) Investors of Filing Deadline in Class Action Lawsuit GlobeNewswire Inc. Feb 06, 03:03 CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA GlobeNewswire Inc. Feb 05, 03:37 CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA GlobeNewswire Inc. Feb 02, 18:12 Kessler Topaz Meltzer & Check, LLP Reminds SAVA Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc. (SAVA) GlobeNewswire Inc. Jan 30, 03:34 CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA GlobeNewswire Inc. Jan 29, 03:47 CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA GlobeNewswire Inc. Jan 25, 18:33 ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAVA GlobeNewswire Inc. Jan 23, 03:46 CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA GlobeNewswire Inc. Jan 23, 02:05 ROSEN, A LEADING NATIONAL FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAVA GlobeNewswire Inc. Jan 23, 02:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kaspi, Applied Therapeutics, Cassava, and MGPI and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jan 22, 03:49 CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. – SAVA GlobeNewswire Inc. Jan 19, 01:35 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAVA GlobeNewswire Inc. Jan 15, 23:57 SAVA Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc. (SAVA) GlobeNewswire Inc. Jan 15, 03:41 CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA GlobeNewswire Inc. Jan 09, 23:48 Cassava Sciences, Inc. (SAVA) Investors: February 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP GlobeNewswire Inc. Jan 09, 03:45 CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA GlobeNewswire Inc. Jan 08, 03:48 CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - SAVA GlobeNewswire Inc. Jan 07, 01:26 Robbins LLP Reminds Investors of the Pending Class Action Against Cassava Sciences, Inc. and Urges SAVA Stockholders to Contact the Firm for Information GlobeNewswire Inc. Jan 05, 17:12 ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAVA GlobeNewswire Inc. Jan 04, 01:52 Class Action Announcement for Cassava Sciences, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Cassava Sciences, Inc.

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.75 12/13/2012 12/08/2012 12/17/2012 12/24/2012
2.00 12/13/2010 10/25/2010 12/01/2010 11/30/-0001